Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults

Subjects

Subjects :

Microbiology
QR1-502
Public aspects of medicine
RA1-1270

Details

Language :

English

ISSN :

20556640

Volume :

2

Issue :

10-11

Database :

Directory of Open Access Journals

Journal :

Journal of Virus Eradication

Publication Type :

Academic Journal

Accession number :

edsdoj.581e2c4872c24a7b87f14680f14b4462

Document Type :

article

Full Text :

https://doi.org/10.1016/S2055-6640(20)31129-8